Chloroquinoxaline sulfonamide: A sulfanilamide antitumor agent entering clinical trials Jason S. FishermanBlaire L. OsbornRobert H. Shoemaker OriginalPaper Pages: 1 - 9
Cytotoxicity of crotoxin on murine erythroleukemia cellsin vitro Robert E. CorinLuis J. ViskatisMartin A. Etcheverry OriginalPaper Pages: 11 - 15
A phase I clinical and pharmacokinetic study of the oral and the oral/ intravenous administration of menogaril Geoffrey R. WeissThomas D. BrownDorothy A. Kasunic OriginalPaper Pages: 17 - 27
Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer Bruce E. JohnsonRobert ParkerDaniel C. Ihde OriginalPaper Pages: 29 - 37
Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma Kapil DhingraNicholas PapadopoulosSewa S. Legha OriginalPaper Pages: 39 - 43
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma Walter H. HarveyThomas R. FlemingJohn S. MacDonald OriginalPaper Pages: 45 - 46
Amonafide treatment of refractory esophageal cancer Elizabeth PoplinTom FlemingMarcel E. Conrad OriginalPaper Pages: 47 - 51
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer David G. PfisterDean BajorinGeorge Bosl OriginalPaper Pages: 53 - 56
Phase II trial of 13-cis-retinoic acid plus interferon-α in recurrent head and neck cancer Narin VoravudScott M. LippmanWaun Ki Hong OriginalPaper Pages: 57 - 60
Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer Malcolm MooreJean MarounJohn Gyves OriginalPaper Pages: 61 - 65
Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma Jaffer A. AjaniJames L. AbbruzzeseKaren Daugherty OriginalPaper Pages: 67 - 69
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer Noa Ben-BaruchAndrea M. DenicoffKenneth H. Cowan OriginalPaper Pages: 71 - 74
Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer G. T. BuddR. M. BukowskiR. Ganapathi OriginalPaper Pages: 75 - 79
Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer Stephen K. WilliamsonJohn CrowleyGeoffrey Weiss OriginalPaper Pages: 81 - 83
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer Jose BaselgaMark G. KrisRobert T. Heelan OriginalPaper Pages: 85 - 86
Phase II study of sulofenur (LY 186641) Nikhil C. MunshiDavid E. SeitzLawrence H. Einhorn OriginalPaper Pages: 87 - 90
Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: A Southwest Oncology Group study Robert ChapmanJohn CrowleyHarry E. Hynes OriginalPaper Pages: 91 - 92
New formulation intravenous melphalan in the treatment of patients with metastitic renal cancer Carla I. Falkson OriginalPaper Pages: 93 - 93